Dialyzer and Dialysis Market - Regional Analysis
North American Market Insights
The dialyzer and dialysis market in North America industry is poised to dominate majority revenue share of 36% by 2035. Growth in the dialyzer and dialysis solutions market in the area is driven by increasing investments made by major companies in North America. End-stage renal disease (ESRD), affects over 808,000 persons in the US; 31% had a kidney transplant and 69% have dialysis. ESKD is 1.6 times more common in men than in women. For example, a June 2021 Managed Healthcare Executive article stated that the pandemic has significantly increased patient interest in home hemodialysis treatments in North American countries due to worries about COVID-19 spreading throughout the community. Tablo is a compact, portable mobile hemodialyzer that can be used in a variety of healthcare settings, such as clinics, hospitals, and patients' homes. It was developed by US-based medical technology company Outset Medical in June 2025 for the treatment of patients with acute and/or chronic renal failure.
APAC Market Insights
The Asia Pacific dialyzer and dialysis market is estimated to be the second-largest by developing at a CAGR of 6.31% in the given time frame. The Asia Pacific market is expected to be worth USD 60.8 billion by the end of 2035, up from USD 27.5 billion in 2025. The market is mostly responsible for the rise in infrastructure spending in the healthcare industry, which includes the opening of new dialysis centers and increased access to medical care. For example, in June 2025, the first kidney dialysis center at a government hospital managed by the state was opened by Indian Medical Education Minister Girish Mahajan. Twelve dialysis machines are available at the facility, with two of those units being designated for HIV and AIDS patients.
